Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic and mucosal protective immunity to pneumococcal surface protein A

D E Briles1, R C Tart, H Y Wu

  • 1Department of Microbiology, University of Alabama at Birmingham 35294-2170, USA.

Annals of the New York Academy of Sciences
|October 25, 1996
PubMed
Summary

Pneumococcal surface protein A (PspA) is a promising vaccine candidate, offering broad protection against pneumococcal infections in mice. A PspA-based vaccine could provide a simple, cost-effective immunization strategy, especially for developing nations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

[Sequential optimization of chromogenic staining order for a novel green substrate in immunohistochemistry double staining].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026

Area of Science:

  • Immunology
  • Vaccinology
  • Microbial pathogenesis

Background:

  • Pneumococcal infections pose a significant global health burden.
  • Current vaccines have limitations in coverage and cost.
  • Pneumococcal surface protein A (PspA) is a key virulence factor and a potential vaccine target.

Purpose of the Study:

  • To evaluate the immunogenicity and protective efficacy of PspA as a vaccine candidate against pneumococcal infections.
  • To assess the cross-reactivity of PspA immunization across different pneumococcal serotypes.
  • To explore the potential of PspA in developing cost-effective vaccines for global health.

Main Methods:

  • Immunization of mice with PspA.
  • Challenge studies with virulent strains of Streptococcus pneumoniae.

Related Experiment Videos

  • Serological analysis to determine cross-reactivity.

    • Main Results:

    • PspA immunization elicited a strong immune response in mice.
    • PspA provided significant protection against fatal pneumococcal infections via various routes of administration (iv, ip, in, it).
    • A single PspA molecule demonstrated cross-protective immunity against diverse serotypes.

    Conclusions:

    • PspA is a highly immunogenic and protective antigen against pneumococcal infections.
    • A PspA-based vaccine, potentially a mixture of PspA variants, could offer broad protection against most pneumococcal strains.
    • PspA represents a viable, cost-effective vaccine strategy, particularly for developing countries, and can serve as a component in conjugate vaccines.